Brain Power: How We’re Winning the Fight Against Stroke—And What It Means for Your Health

Why It Matters

Extending the stroke treatment window and introducing safer anticoagulants reshape care pathways, driving demand for advanced therapies and preventive health programs that can lower costs and improve patient outcomes.

Key Takeaways

• Stroke treatment window expanded from 3 to 24 hours.
• Controlling hypertension cuts stroke risk by up to 40%.
• Smoking cessation reduces stroke risk 50% within one year.
• New oral anticoagulants and factor XI inhibitors improve safety.
• Statins and aggressive LDL lowering lower recurrent stroke rates.

Summary

Dr. Greg Alers, co‑founder of the Stanford Stroke Center, opened the Health Matters session by highlighting a paradigm shift in stroke care: the therapeutic window for clot‑busting treatment has been extended from three hours to a full 24 hours, dramatically increasing the number of patients who can benefit. He framed stroke as a "brain attack" caused by sudden blood‑flow disruption, emphasizing the need to differentiate between ischemic clots and hemorrhagic bleeds before treatment. The presentation detailed the primary preventable drivers of stroke—high blood pressure, smoking, atherosclerosis, atrial fibrillation, diabetes, and high LDL cholesterol. Alers cited data showing that optimal blood‑pressure control can slash stroke incidence by roughly 40%, while quitting smoking cuts risk in half within a year. He also underscored the role of statins, aggressive LDL targets, and antiplatelet therapy in reducing recurrent events. Memorable moments included the "Drano for the brain" analogy describing tissue plasminogen activator (tPA) dissolving clots, and the Sparkle trial that debunked myths about statin‑induced muscle pain. Alers highlighted emerging factor XI antagonists, which promise anticoagulation without the usual bleeding penalty, and praised the collaborative, multidisciplinary model that Stanford pioneered decades ago. The broader implication is clear: expanded treatment windows, novel anticoagulants, and aggressive risk‑factor management create new opportunities for hospitals, pharmaceutical firms, and insurers to improve outcomes while reducing long‑term costs. Public health campaigns focused on hypertension and smoking cessation become even more urgent as they now directly translate into measurable reductions in stroke burden.

Original Description

Brain Power: How We’re Winning the Fight Against Stroke—and What It Means for Your Health

Gregory W. Albers, MD, Coyote Foundation Professor and Professor of Neurology and Neurological Sciences

Thanks to transformative work at Stanford, stroke treatment has undergone a revolution—one that could make a real difference in your life.

For decades, stroke patients had a narrow three-hour window to receive treatment, yet today, groundbreaking research led by Dr. Albers has changed that entirely. By pioneering advanced imaging techniques that show which brain tissue can be saved and improving methods to remove clots, he helped extend that window to a full 24 hours—a breakthrough that’s giving patients here and everywhere not just a chance at survival, but at full recovery.

In this talk, Dr. Albers will take you behind the scenes of this discovery: how it came about, what it means for stroke care today, and—most importantly—the practical steps you can take to reduce your own risk of stroke. You’ll leave informed, empowered, and equipped with knowledge that could help you or someone you love.

May 16, 2026, at Health Matters 2026. Health Matters is Stanford Medicine's annual community event: healthmatters.stanford.edu.